{"database": "openregs", "table": "documents", "is_view": false, "human_description_en": "where agency_id = \"DEA\" and document_type = \"Supporting & Related Material\" sorted by posted_date descending", "rows": [["DEA-2026-0133-0004", "DEA", "DEA-2026-0133", "DEA-1442 HHS Letter to DEA 06112025", "Supporting & Related Material", null, "2026-01-20T05:00:00Z", 2026, 1, null, null, "2026-01-20T23:39:08Z", null, 0, 0, "09000064b9162339"], ["DEA-2026-0133-0003", "DEA", "DEA-2026-0133", "DEA-1442 DEA Letter to HHS 11012024", "Supporting & Related Material", null, "2026-01-20T05:00:00Z", 2026, 1, null, null, "2026-02-12T21:01:03Z", null, 0, 1, "09000064b9162338"], ["DEA-2026-0133-0002", "DEA", "DEA-2026-0133", "DEA-1442 3-Factor Analysis 2-Fluorodeschloroketamine January 2026", "Supporting & Related Material", null, "2026-01-20T05:00:00Z", 2026, 1, null, null, "2026-01-20T23:39:02Z", null, 0, 0, "09000064b9162337"], ["DEA-2026-0133-0005", "DEA", "DEA-2026-0133", "DEA-1442 HHS Letter to DEA 11082024", "Supporting & Related Material", null, "2026-01-20T05:00:00Z", 2026, 1, null, null, "2026-01-20T23:39:10Z", null, 0, 0, "09000064b916233a"], ["DEA-2026-0133-0006", "DEA", "DEA-2026-0133", "DEA-1442 DEA Letter to HHS 05282025", "Supporting & Related Material", null, "2026-01-20T05:00:00Z", 2026, 1, null, null, "2026-02-12T21:01:51Z", null, 0, 1, "09000064b916233b"], ["DEA-2025-0918-0003", "DEA", "DEA-2025-0918", "251203 OASH to DEA draft letter 4 synthetic cannabinoids 8FA_signed 12032025", "Supporting & Related Material", null, "2025-12-18T05:00:00Z", 2025, 12, null, null, "2025-12-18T19:22:36Z", null, 0, 0, "09000064b90eed87"], ["DEA-2025-0918-0005", "DEA", "DEA-2025-0918", "4F-MDMB-BUTICA ADB-4en-PINACA 5F-EDMB-PICA MMB-FUBICA 8-Factor Analysis December 2025 DEA", "Supporting & Related Material", null, "2025-12-18T05:00:00Z", 2025, 12, null, null, "2025-12-18T19:22:42Z", null, 0, 0, "09000064b90eed89"], ["DEA-2025-0918-0004", "DEA", "DEA-2025-0918", "4F-MDMB-BUTICA ADB-4en-PINACA 5F-EDMB-PICA MMB-FUBICA 8-Factor December 2025 HHS", "Supporting & Related Material", null, "2025-12-18T05:00:00Z", 2025, 12, null, null, "2025-12-18T19:22:39Z", null, 0, 0, "09000064b90eed88"], ["DEA-2025-0885-0003", "DEA", "DEA-2025-0885", "HHS letter to DEA Bromazolam 07102025", "Supporting & Related Material", null, "2025-12-15T05:00:00Z", 2025, 12, null, null, "2025-12-15T20:47:51Z", null, 0, 0, "09000064b90d40f8"], ["DEA-2025-0885-0002", "DEA", "DEA-2025-0885", "HHS letter to DEA Bromazolam 06282024", "Supporting & Related Material", null, "2025-12-15T05:00:00Z", 2025, 12, null, null, "2025-12-15T20:47:46Z", null, 0, 0, "09000064b90d40f6"], ["DEA-2025-0885-0004", "DEA", "DEA-2025-0885", "DEA 3-Factor Analysis Bromazolam December 2025", "Supporting & Related Material", null, "2025-12-15T05:00:00Z", 2025, 12, null, null, "2025-12-15T20:47:54Z", null, 0, 0, "09000064b90d40f7"], ["DEA-2025-0852-0005", "DEA", "DEA-2025-0852", "HHS Letter to DEA cumyl-PEGACLONE_112024", "Supporting & Related Material", null, "2025-12-12T05:00:00Z", 2025, 12, null, null, "2025-12-13T02:46:04Z", null, 0, 0, "09000064b90cb028"], ["DEA-2025-0852-0007", "DEA", "DEA-2025-0852", "HHS Letter to DEA cumyl-PEGACLONE_112024", "Supporting & Related Material", null, "2025-12-12T05:00:00Z", 2025, 12, null, null, "2025-12-13T02:50:33Z", null, 0, 0, "09000064b90cb02a"], ["DEA-2025-0852-0006", "DEA", "DEA-2025-0852", "CUMYL-PEGACLONE HHS 8 Factor Review", "Supporting & Related Material", null, "2025-12-12T05:00:00Z", 2025, 12, null, null, "2025-12-13T02:50:28Z", null, 0, 0, "09000064b90cb029"], ["DEA-2025-0852-0008", "DEA", "DEA-2025-0852", "CUMYL PEGACLONE DEA 8-Factor Analysis_1222025", "Supporting & Related Material", null, "2025-12-12T05:00:00Z", 2025, 12, null, null, "2025-12-13T02:50:36Z", null, 0, 0, "09000064b90cb02b"], ["DEA-2025-0852-0004", "DEA", "DEA-2025-0852", "CUMYL-PEGACLONE HHS 8 Factor Review", "Supporting & Related Material", null, "2025-12-12T05:00:00Z", 2025, 12, null, null, "2025-12-13T02:46:02Z", null, 0, 0, "09000064b90cb027"], ["DEA-2025-0852-0003", "DEA", "DEA-2025-0852", "CUMYL PEGACLONE DEA 8-Factor Analysis_1222025", "Supporting & Related Material", null, "2025-12-12T05:00:00Z", 2025, 12, null, null, "2025-12-13T02:45:59Z", null, 0, 0, "09000064b90cb026"], ["DEA-2025-0588-0002", "DEA", "DEA-2025-0588", "Seven benzimidazole opioids 811h no objection ASH to DEA 22Apr2025.AA", "Supporting & Related Material", null, "2025-10-16T04:00:00Z", 2025, 10, null, null, "2025-10-17T03:33:17Z", null, 0, 0, "09000064b902eca3"], ["DEA-2025-0555-0003", "DEA", "DEA-2025-0555", "8FA MDMB-4en-PINACA", "Supporting & Related Material", null, "2025-10-03T04:00:00Z", 2025, 10, null, null, "2025-10-03T22:46:34Z", null, 0, 0, "09000064b8ff1b92"], ["DEA-2025-0555-0004", "DEA", "DEA-2025-0555", "SIGNED - OASH to DEA Ltr 8FA MDMB-PINACA.VAS", "Supporting & Related Material", null, "2025-10-03T04:00:00Z", 2025, 10, null, null, "2025-10-03T22:46:38Z", null, 0, 0, "09000064b8ff1b94"], ["DEA-2025-0555-0002", "DEA", "DEA-2025-0555", "MDMB-4en-PINACA 8F Oct 2025", "Supporting & Related Material", null, "2025-10-02T04:00:00Z", 2025, 10, null, null, "2025-10-03T01:16:43Z", null, 0, 0, "09000064b8fefe68"], ["DEA-2025-0192-0002", "DEA", "DEA-2025-0192", "DEA-1494 Three Factor Analysis for Temporary Control of Seven Benzimidazole-Opioids", "Supporting & Related Material", null, "2025-08-01T04:00:00Z", 2025, 8, null, null, "2025-08-02T00:46:00Z", null, 0, 0, "09000064b8ecca29"], ["DEA-2022-0145-0008", "DEA", "DEA-2022-0145", "DEA989 HHS 8-Factor Analysis", "Supporting & Related Material", null, "2025-07-25T04:00:00Z", 2025, 7, null, null, "2025-07-25T21:33:08Z", null, 0, 0, "09000064b8ea2f07"], ["DEA-2022-0145-0007", "DEA", "DEA-2022-0145", "DEA989 DEA 8-Factor Analysis", "Supporting & Related Material", null, "2025-07-25T04:00:00Z", 2025, 7, null, null, "2025-07-25T21:33:05Z", null, 0, 0, "09000064b8e9d6f4"], ["DEA-2025-0078-0003", "DEA", "DEA-2025-0078", "DEA Eight Factor 3 FRS_2025", "Supporting & Related Material", null, "2025-06-13T04:00:00Z", 2025, 6, null, null, "2025-06-13T19:26:14Z", null, 0, 0, "09000064b8e081ed"], ["DEA-2025-0078-0002", "DEA", "DEA-2025-0078", "3 FRS 8FA Review", "Supporting & Related Material", null, "2025-06-13T04:00:00Z", 2025, 6, null, null, "2025-06-13T19:25:56Z", null, 0, 0, "09000064b8e081ec"], ["DEA-2025-0081-0004", "DEA", "DEA-2025-0081", "SIGNED - OASH to DEA Ltr 3-MeO PCP.VAS", "Supporting & Related Material", null, "2025-06-10T04:00:00Z", 2025, 6, null, null, "2025-06-10T17:28:14Z", null, 0, 0, "09000064b8ddfd9d"], ["DEA-2025-0081-0002", "DEA", "DEA-2025-0081", "DEA1146 8 Factor 3-MeO-PCP", "Supporting & Related Material", null, "2025-06-10T04:00:00Z", 2025, 6, null, null, "2025-06-10T17:27:40Z", null, 0, 0, "09000064b8ddfd9b"], ["DEA-2025-0081-0003", "DEA", "DEA-2025-0081", "HHS 8FA 3-MeO-PCP Review", "Supporting & Related Material", null, "2025-06-10T04:00:00Z", 2025, 6, null, null, "2025-06-10T17:27:57Z", null, 0, 0, "09000064b8ddfd9c"], ["DEA-2025-0075-0002", "DEA", "DEA-2025-0075", "8FA HHS Report Review 4-Fluoroamphetamine", "Supporting & Related Material", null, "2025-06-03T04:00:00Z", 2025, 6, null, null, "2025-06-03T21:10:52Z", null, 0, 0, "09000064b8dd15a3"], ["DEA-2025-0075-0003", "DEA", "DEA-2025-0075", "FINAL SIGNED - OASH Letter to DEA Ltr 4-Fluroamphetamine", "Supporting & Related Material", null, "2025-06-03T04:00:00Z", 2025, 6, null, null, "2025-06-03T21:11:11Z", null, 0, 0, "09000064b8dd15a4"], ["DEA-2025-0075-0004", "DEA", "DEA-2025-0075", "DEA1180 Background Review 4-Fluoroamphetamine", "Supporting & Related Material", null, "2025-06-03T04:00:00Z", 2025, 6, null, null, "2025-06-03T21:11:41Z", null, 0, 0, "09000064b8dd15a5"], ["DEA-2024-0148-0004", "DEA", "DEA-2024-0148", "7-FRS HHS 8FA Review", "Supporting & Related Material", null, "2024-12-31T05:00:00Z", 2024, 12, null, null, "2024-12-31T17:10:13Z", null, 0, 0, "09000064868970a9"], ["DEA-2024-0148-0003", "DEA", "DEA-2024-0148", "SIGNED OASH to DEA letter 7FRS 8FA_10.25.24", "Supporting & Related Material", null, "2024-12-31T05:00:00Z", 2024, 12, null, null, "2024-12-31T17:09:46Z", null, 0, 0, "09000064868970aa"], ["DEA-2024-0148-0005", "DEA", "DEA-2024-0148", "7-FRS DEA 8 Factor Analysis_2024", "Supporting & Related Material", null, "2024-12-31T05:00:00Z", 2024, 12, null, null, "2024-12-31T17:10:26Z", null, 0, 0, "09000064868970a8"], ["DEA-2024-0144-0003", "DEA", "DEA-2024-0144", "4-CMC HHS 8FA Review", "Supporting & Related Material", null, "2024-12-30T05:00:00Z", 2024, 12, null, null, "2024-12-30T17:15:04Z", null, 0, 0, "0900006486891597"], ["DEA-2024-0144-0004", "DEA", "DEA-2024-0144", "4-CMC DEA 8 Factor Analysis_092024", "Supporting & Related Material", null, "2024-12-30T05:00:00Z", 2024, 12, null, null, "2024-12-30T17:15:09Z", null, 0, 0, "0900006486891598"], ["DEA-2024-0144-0002", "DEA", "DEA-2024-0144", "SIGNED - OASH to DEA Ltr 4-CMC.VAS", "Supporting & Related Material", null, "2024-12-30T05:00:00Z", 2024, 12, null, null, "2024-12-30T17:15:00Z", null, 0, 0, "0900006486891596"], ["DEA-2024-0118-0002", "DEA", "DEA-2024-0118", "DEA-1337 Three Factor Analysis for Temporary Control of N-pyrrolidino metonitazene and N-pyrrolidino protonitazene", "Supporting & Related Material", null, "2024-09-17T04:00:00Z", 2024, 9, null, null, "2024-09-17T20:07:23Z", null, 0, 0, "0900006486732f62"], ["DEA-2024-0059-0007", "DEA", "DEA-2024-0059", "2016-17954-DEA-426", "Supporting & Related Material", null, "2024-05-21T04:00:00Z", 2024, 5, null, null, "2024-05-21T13:55:44Z", null, 0, 0, "090000648657624c"], ["DEA-2024-0059-0006", "DEA", "DEA-2024-0059", "2016-17954-HHS", "Supporting & Related Material", null, "2024-05-21T04:00:00Z", 2024, 5, null, null, "2024-05-21T13:55:31Z", null, 0, 0, "090000648657624b"], ["DEA-2024-0059-0004", "DEA", "DEA-2024-0059", "2024-04-11 - AAG Fonzone - Marijuana Rescheduling", "Supporting & Related Material", null, "2024-05-21T04:00:00Z", 2024, 5, null, null, "2024-05-21T13:46:37Z", null, 0, 0, "0900006486576249"], ["DEA-2024-0059-0005", "DEA", "DEA-2024-0059", "2016-17960-DEA-427", "Supporting & Related Material", null, "2024-05-21T04:00:00Z", 2024, 5, null, null, "2024-05-21T13:55:07Z", null, 0, 0, "090000648657624a"], ["DEA-2023-0168-0004", "DEA", "DEA-2023-0168", "FINAL SIGNED ASH Letter to DEA_DOI-DOC_09.28.2020", "Supporting & Related Material", null, "2023-12-14T05:00:00Z", 2023, 12, null, null, "2023-12-14T16:35:38Z", null, 0, 0, "090000648633a0c2"], ["DEA-2023-0168-0005", "DEA", "DEA-2023-0168", "DEA1156 Eight-Factor Review DOI DOC 102023", "Supporting & Related Material", null, "2023-12-14T05:00:00Z", 2023, 12, null, null, "2023-12-14T16:35:46Z", null, 0, 0, "090000648633a0c3"], ["DEA-2023-0049-0006", "DEA", "DEA-2023-0049", "SIGNED - 6 Cannabinoids 811h no objection ASH to DEA.VAS (003) MDC 03072022", "Supporting & Related Material", null, "2023-12-12T05:00:00Z", 2023, 12, null, null, "2023-12-12T15:13:43Z", null, 0, 0, "0900006486329b0d"], ["DEA-2023-0049-0005", "DEA", "DEA-2023-0049", "6 SCs 3 Factor December 2023", "Supporting & Related Material", null, "2023-12-12T05:00:00Z", 2023, 12, null, null, "2023-12-12T15:13:34Z", null, 0, 0, "09000064863298d2"], ["DEA-2023-0147-0002", "DEA", "DEA-2023-0147", "DEA 1143 Three Factor Analysis for Temporary Control of N-desethyl isotonitazene and N-piperidinyl etonitazene", "Supporting & Related Material", null, "2023-11-06T05:00:00Z", 2023, 11, null, null, "2023-11-06T19:47:05Z", null, 0, 0, "090000648621047f"], ["DEA-2023-0149-0002", "DEA", "DEA-2023-0149", "DEA1258 Zuranolone Eight Factors of Analysis September 2023", "Supporting & Related Material", null, "2023-10-31T04:00:00Z", 2023, 10, null, null, "2023-10-31T17:39:29Z", null, 0, 0, "09000064861a5b33"], ["DEA-2023-0149-0003", "DEA", "DEA-2023-0149", "ASH to DEA Letter and 8FA Zuranolone 12Jul2023", "Supporting & Related Material", null, "2023-10-31T04:00:00Z", 2023, 10, null, null, "2023-10-31T17:39:40Z", null, 0, 0, "09000064861a5b32"], ["DEA-2023-0129-0002", "DEA", "DEA-2023-0129", "Ethylphenidate 8-Factor DOE 23-103", "Supporting & Related Material", null, "2023-09-22T04:00:00Z", 2023, 9, null, null, "2023-09-22T19:17:09Z", null, 0, 0, "0900006485fe8668"], ["DEA-2023-0049-0003", "DEA", "DEA-2023-0049", "SIGNED - 6 Cannabinoids 811h no objection ASH to DEA.VAS (003) MDC 03072022", "Supporting & Related Material", null, "2023-05-11T04:00:00Z", 2023, 5, null, null, "2023-05-11T12:54:36Z", null, 0, 0, "09000064859f43b8"], ["DEA-2023-0058-0002", "DEA", "DEA-2023-0058", "FINAL SIGNED - ASHtoDEA draft letter 9 Fentanyl-Related Substances.VAS", "Supporting & Related Material", null, "2023-04-14T04:00:00Z", 2023, 4, null, null, "2023-04-14T12:21:41Z", null, 0, 0, "09000064859444a7"], ["DEA-2023-0058-0003", "DEA", "DEA-2023-0058", "DEA1036 Nine fentanyls 8-factor 04.06.2023", "Supporting & Related Material", null, "2023-04-14T04:00:00Z", 2023, 4, null, null, "2023-04-14T12:21:56Z", null, 0, 0, "09000064859444a8"], ["DEA-2023-0058-0004", "DEA", "DEA-2023-0058", "8FA Nine Fentanyls", "Supporting & Related Material", null, "2023-04-14T04:00:00Z", 2023, 4, null, null, "2023-04-14T12:22:09Z", null, 0, 0, "09000064859444a9"], ["DEA-2023-0049-0002", "DEA", "DEA-2023-0049", "6 SCs 3 Factor April 2022", "Supporting & Related Material", null, "2023-04-04T04:00:00Z", 2023, 4, null, null, "2023-04-04T15:48:44Z", null, 0, 0, "09000064858c4960"], ["DEA-2022-0068-0005", "DEA", "DEA-2022-0068", "FINAL SIGNED - Fenfluramine Letter and 8FA review 16Apr2021", "Supporting & Related Material", null, "2023-01-03T05:00:00Z", 2023, 1, null, null, "2023-01-03T13:21:30Z", null, 0, 0, "090000648557e6b8"], ["DEA-2022-0068-0004", "DEA", "DEA-2022-0068", "DEA945 Eight Factor Analysis Fenfluramine 012022", "Supporting & Related Material", null, "2023-01-03T05:00:00Z", 2023, 1, null, null, "2023-01-03T13:21:26Z", null, 0, 0, "090000648556a0f0"], ["DEA-2022-0145-0002", "DEA", "DEA-2022-0145", "DEA 3-Factor Analysis Etizolam Flualprazolam Clonazolam Diclazepam Flu...", "Supporting & Related Material", null, "2022-12-23T05:00:00Z", 2022, 12, null, null, "2022-12-23T12:56:32Z", null, 0, 0, "090000648554cfbd"], ["DEA-2022-0145-0003", "DEA", "DEA-2022-0145", "SIGNED - Benzodiazepines 811h no objection ASH to DEA.VAS", "Supporting & Related Material", null, "2022-12-23T05:00:00Z", 2022, 12, null, null, "2022-12-23T12:56:40Z", null, 0, 0, "090000648554cfbe"], ["DEA-2022-0051-0004", "DEA", "DEA-2022-0051", "Ganaxolone eight factor_DEA", "Supporting & Related Material", null, "2022-11-09T05:00:00Z", 2022, 11, null, null, "2022-11-09T16:41:53Z", null, 0, 0, "090000648549e073"], ["DEA-2022-0051-0003", "DEA", "DEA-2022-0051", "Ganaxolone 8FA", "Supporting & Related Material", null, "2022-11-09T05:00:00Z", 2022, 11, null, null, "2022-11-09T16:41:43Z", null, 0, 0, "090000648549e072"], ["DEA-2022-0108-0002", "DEA", "DEA-2022-0108", "Bulk Manufacturer Application - Chattem Chemicals - Correction (2022-24105) - DEA1083", "Supporting & Related Material", null, "2022-11-08T05:00:00Z", 2022, 11, null, null, "2022-11-08T13:25:42Z", null, 0, 0, "0900006485499735"], ["DEA-2022-0026-0003", "DEA", "DEA-2022-0026", "DEA824 DEA 8-factor_DOIandDOC_DOE_082021", "Supporting & Related Material", null, "2022-04-11T04:00:00Z", 2022, 4, null, null, "2022-04-11T14:27:34Z", null, 0, 0, "090000648500b68f"], ["DEA-2022-0026-0002", "DEA", "DEA-2022-0026", "FINAL SIGNED ASH Letter to DEA_DOI-DOC_09.28.2020", "Supporting & Related Material", null, "2022-04-11T04:00:00Z", 2022, 4, null, null, "2022-04-11T14:27:28Z", null, 0, 0, "090000648500b69e"], ["DEA-2022-0025-0003", "DEA", "DEA-2022-0025", "Daridorexant eight factor document DOE", "Supporting & Related Material", null, "2022-04-07T04:00:00Z", 2022, 4, null, null, "2022-04-07T13:15:47Z", null, 0, 0, "0900006484fff9ea"], ["DEA-2022-0025-0002", "DEA", "DEA-2022-0025", "Daridorexant ASHtoDEA 22Dec2021", "Supporting & Related Material", null, "2022-04-07T04:00:00Z", 2022, 4, null, null, "2022-04-07T13:15:39Z", null, 0, 0, "0900006484fff9e9"], ["DEA-2022-0025-0004", "DEA", "DEA-2022-0025", "DCT to DEA daridorexant NDA approval notification", "Supporting & Related Material", null, "2022-04-07T04:00:00Z", 2022, 4, null, null, "2022-04-07T13:15:53Z", null, 0, 0, "0900006484fff7f5"], ["DEA-2022-0001-0002", "DEA", "DEA-2022-0001", "4-OH-DIPT Schedule I_05-17-2012", "Supporting & Related Material", null, "2022-01-14T05:00:00Z", 2022, 1, null, null, "2022-01-14T18:38:33Z", null, 0, 0, "0900006484f21925"], ["DEA-2022-0001-0004", "DEA", "DEA-2022-0001", "5-MeO-DET Schedule I_05-17-2012", "Supporting & Related Material", null, "2022-01-14T05:00:00Z", 2022, 1, null, null, "2022-01-14T18:38:55Z", null, 0, 0, "0900006484f21930"], ["DEA-2022-0001-0006", "DEA", "DEA-2022-0001", "DIPT Schedule I_08-14-2012", "Supporting & Related Material", null, "2022-01-14T05:00:00Z", 2022, 1, null, null, "2022-01-14T18:39:32Z", null, 0, 0, "0900006484f21933"], ["DEA-2022-0001-0003", "DEA", "DEA-2022-0001", "5-MeO-AMT Schedule I_04-03-2012", "Supporting & Related Material", null, "2022-01-14T05:00:00Z", 2022, 1, null, null, "2022-01-14T18:38:44Z", null, 0, 0, "0900006484f21926"], ["DEA-2022-0001-0005", "DEA", "DEA-2022-0001", "Five tryptamines Eight-factor analysis DEA 082021", "Supporting & Related Material", null, "2022-01-14T05:00:00Z", 2022, 1, null, null, "2022-01-14T18:39:21Z", null, 0, 0, "0900006484f21932"], ["DEA-2022-0001-0007", "DEA", "DEA-2022-0001", "5-MeO-MIPT Schedule I_05-17-2012", "Supporting & Related Material", null, "2022-01-14T05:00:00Z", 2022, 1, null, null, "2022-01-14T18:39:43Z", null, 0, 0, "0900006484f21934"], ["DEA-2021-0031-0003", "DEA", "DEA-2021-0031", "Three Factor Analysis for Temporary Control of 7 benzimidazole-opioids", "Supporting & Related Material", null, "2021-12-13T05:00:00Z", 2021, 12, null, null, "2021-12-13T15:48:07Z", null, 0, 0, "0900006484ec1629"], ["DEA-2021-0030-0003", "DEA", "DEA-2021-0030", "DEA568 8 Factor Methoxetamine 092021", "Supporting & Related Material", null, "2021-12-08T05:00:00Z", 2021, 12, null, null, "2021-12-08T20:11:47Z", null, 0, 0, "0900006484eac53f"], ["DEA-2021-0030-0002", "DEA", "DEA-2021-0030", "HHS Scheduling recommendation Methoxetamine", "Supporting & Related Material", null, "2021-12-08T05:00:00Z", 2021, 12, null, null, "2021-12-08T20:11:38Z", null, 0, 0, "0900006484eac53d"], ["DEA-2021-0031-0002", "DEA", "DEA-2021-0031", "Three Factor Analysis for Temporary Control of 7 benzimidazole-opioids 11042021", "Supporting & Related Material", null, "2021-12-08T00:00:00Z", 2021, 12, null, null, "2021-12-13T15:47:53Z", null, 0, 1, "0900006484eac53c"], ["DEA-2021-0025-0003", "DEA", "DEA-2021-0025", "DEA837 8FA 18F  FP-CIT DOE-21-632", "Supporting & Related Material", null, "2021-11-04T04:00:00Z", 2021, 11, null, null, "2021-11-04T13:48:03Z", null, 0, 0, "0900006484e1a226"], ["DEA-2021-0025-0002", "DEA", "DEA-2021-0025", "FINAL SIGNED - Fluoroseek Letter and review 16Apr2021", "Supporting & Related Material", null, "2021-11-04T04:00:00Z", 2021, 11, null, null, "2021-11-04T13:47:50Z", null, 0, 0, "0900006484e1a93b"], ["DEA-2021-0012-0002", "DEA", "DEA-2021-0012", "Mesocarb 8 Factor August 2021", "Supporting & Related Material", null, "2021-08-17T04:00:00Z", 2021, 8, null, null, "2021-08-17T15:02:59Z", null, 0, 0, "0900006484c6c92b"], ["DEA-2021-0012-0003", "DEA", "DEA-2021-0012", "HHS recommendation on Mesocarb Apr 3 2012", "Supporting & Related Material", null, "2021-08-17T04:00:00Z", 2021, 8, null, null, "2021-08-17T15:05:58Z", null, 0, 0, "0900006484c6c92d"], ["DEA-2021-0011-0002", "DEA", "DEA-2021-0011", "Aminpetine 8-factor July 2021", "Supporting & Related Material", null, "2021-07-27T04:00:00Z", 2021, 7, null, null, "2021-07-27T13:52:16Z", null, 0, 0, "0900006484c127b0"], ["DEA-2021-0011-0003", "DEA", "DEA-2021-0011", "Amineptine (DHHS) 12-01-2011", "Supporting & Related Material", null, "2021-07-27T04:00:00Z", 2021, 7, null, null, "2021-07-27T13:52:23Z", null, 0, 0, "0900006484c127b1"], ["DEA-2019-0004-0004", "DEA", "DEA-2019-0004", "DEA_495_8 Factor_Analysis", "Supporting & Related Material", null, "2021-07-16T04:00:00Z", 2021, 7, null, null, "2021-08-18T13:26:26Z", null, 0, 0, "0900006484bfe470"], ["DEA-2019-0004-0005", "DEA", "DEA-2019-0004", "OASH to DEA Letter and 8FA 6 Cathinones SIGNED 7.8.2021", "Supporting & Related Material", null, "2021-07-16T04:00:00Z", 2021, 7, null, null, "2021-08-18T13:26:40Z", null, 0, 0, "0900006484bfe471"], ["DEA-2020-0003-0012", "DEA", "DEA-2020-0003", "Lasmiditan HHS ltr and 8 Factor Analysis 10-23-2019", "Supporting & Related Material", null, "2021-05-25T04:00:00Z", 2021, 5, null, null, "2021-05-25T16:24:36Z", null, 0, 0, "0900006484b34b97"], ["DEA-2020-0003-0011", "DEA", "DEA-2020-0003", "8F Lasmiditan 08062020", "Supporting & Related Material", null, "2021-05-25T04:00:00Z", 2021, 5, null, null, "2021-05-25T16:16:24Z", null, 0, 0, "0900006484b34b5d"], ["DEA-2021-0010-0002", "DEA", "DEA-2021-0010", "Serdexmethylphenidate 8-Factor Analysis DEA 04-2021", "Supporting & Related Material", null, "2021-05-19T04:00:00Z", 2021, 5, null, null, "2021-05-19T13:04:09Z", null, 0, 0, "0900006484b1ad0b"], ["DEA-2021-0010-0003", "DEA", "DEA-2021-0010", "8FA Serdexmethylphenidate 01Mar2021", "Supporting & Related Material", null, "2021-05-19T04:00:00Z", 2021, 5, null, null, "2021-05-19T13:04:25Z", null, 0, 0, "0900006484b1ad0c"], ["DEA-2019-0002-0006", "DEA", "DEA-2019-0002", "HHS Letter 09062018 5F-EDMB-PINACA 5F-MDMB-PICA FUB-AKB48 5F-CUMYL-PINACA FUB-144", "Supporting & Related Material", null, "2021-04-02T04:00:00Z", 2021, 4, null, null, "2021-04-02T12:38:48Z", null, 0, 0, "0900006484a93780"], ["DEA-2019-0002-0007", "DEA", "DEA-2019-0002", "5 SC 8-Factor for permanent control March 2021", "Supporting & Related Material", null, "2021-04-02T04:00:00Z", 2021, 4, null, null, "2021-04-02T12:40:02Z", null, 0, 0, "0900006484a9376a"], ["DEA-2019-0002-0008", "DEA", "DEA-2019-0002", "Final Signed OASH to DEA Letter Five Synthetic Cannabinoids 2.26.21", "Supporting & Related Material", null, "2021-04-02T04:00:00Z", 2021, 4, null, null, "2021-04-02T12:43:55Z", null, 0, 0, "0900006484a93786"], ["DEA-2021-0007-0002", "DEA", "DEA-2021-0007", "FINAL SIGNED - OASH Letter to DEA Four FRS.VAS", "Supporting & Related Material", null, "2021-03-22T04:00:00Z", 2021, 3, null, null, "2021-03-22T14:52:30Z", null, 0, 0, "0900006484a73bef"], ["DEA-2021-0007-0003", "DEA", "DEA-2021-0007", "Four fentanyl related substances DEA 8-Factor", "Supporting & Related Material", null, "2021-03-22T04:00:00Z", 2021, 3, null, null, "2021-03-22T14:57:00Z", null, 0, 0, "0900006484a73c3e"], ["DEA-2021-0006-0003", "DEA", "DEA-2021-0006", "Signed OASH Letter to DEA with Review 02Jul20", "Supporting & Related Material", null, "2021-03-09T05:00:00Z", 2021, 3, null, null, "2021-03-09T14:01:14Z", null, 0, 0, "0900006484a64123"], ["DEA-2021-0006-0002", "DEA", "DEA-2021-0006", "DEA Eight-Factor Analysis for 10 FRS", "Supporting & Related Material", null, "2021-03-09T05:00:00Z", 2021, 3, null, null, "2021-03-09T14:01:02Z", null, 0, 0, "0900006484a64120"], ["DEA-2020-0020-0003", "DEA", "DEA-2020-0020", "5 SCs 8-Factor for permanent control 06302020", "Supporting & Related Material", null, "2021-02-02T05:00:00Z", 2021, 2, null, null, "2021-02-02T15:27:15Z", null, 0, 0, "0900006484a1430f"], ["DEA-2020-0020-0005", "DEA", "DEA-2020-0020", "Five Syn Cannabinoids 8FA Report", "Supporting & Related Material", null, "2021-02-02T05:00:00Z", 2021, 2, null, null, "2021-02-02T15:27:43Z", null, 0, 0, "0900006484a14311"], ["DEA-2020-0020-0004", "DEA", "DEA-2020-0020", "FINAL SIGNED Response Letter to Uttam Dhillon_5.29.2020", "Supporting & Related Material", null, "2021-02-02T05:00:00Z", 2021, 2, null, null, "2021-02-02T15:27:32Z", null, 0, 0, "0900006484a14310"]], "truncated": false, "filtered_table_rows_count": 307, "expanded_columns": [], "expandable_columns": [[{"column": "docket_id", "other_table": "dockets", "other_column": "id"}, "title"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "units": {}, "query": {"sql": "select id, agency_id, docket_id, title, document_type, subtype, posted_date, posted_year, posted_month, comment_start_date, comment_end_date, last_modified, fr_doc_num, open_for_comment, withdrawn, object_id from documents where \"agency_id\" = :p0 and \"document_type\" = :p1 order by posted_date desc limit 101", "params": {"p0": "DEA", "p1": "Supporting & Related Material"}}, "facet_results": {"agency_id": {"name": "agency_id", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=DEA&document_type=Supporting+%26+Related+Material", "results": [{"value": "DEA", "label": "DEA", "count": 307, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?document_type=Supporting+%26+Related+Material", "selected": true}], "truncated": false}, "document_type": {"name": "document_type", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=DEA&document_type=Supporting+%26+Related+Material", "results": [{"value": "Supporting & Related Material", "label": "Supporting & Related Material", "count": 307, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=DEA", "selected": true}], "truncated": false}, "posted_year": {"name": "posted_year", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=DEA&document_type=Supporting+%26+Related+Material", "results": [{"value": 2021, "label": 2021, "count": 28, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=DEA&document_type=Supporting+%26+Related+Material&posted_year=2021", "selected": false}, {"value": 2025, "label": 2025, "count": 27, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=DEA&document_type=Supporting+%26+Related+Material&posted_year=2025", "selected": false}, {"value": 2016, "label": 2016, "count": 26, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=DEA&document_type=Supporting+%26+Related+Material&posted_year=2016", "selected": false}, {"value": 2020, "label": 2020, "count": 25, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=DEA&document_type=Supporting+%26+Related+Material&posted_year=2020", "selected": false}, {"value": 2017, "label": 2017, "count": 21, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=DEA&document_type=Supporting+%26+Related+Material&posted_year=2017", "selected": false}, {"value": 2019, "label": 2019, "count": 18, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=DEA&document_type=Supporting+%26+Related+Material&posted_year=2019", "selected": false}, {"value": 2009, "label": 2009, "count": 17, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=DEA&document_type=Supporting+%26+Related+Material&posted_year=2009", "selected": false}, {"value": 2013, "label": 2013, "count": 17, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=DEA&document_type=Supporting+%26+Related+Material&posted_year=2013", "selected": false}, {"value": 2014, "label": 2014, "count": 16, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=DEA&document_type=Supporting+%26+Related+Material&posted_year=2014", "selected": false}, {"value": 2015, "label": 2015, "count": 16, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=DEA&document_type=Supporting+%26+Related+Material&posted_year=2015", "selected": false}, {"value": 2022, "label": 2022, "count": 16, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=DEA&document_type=Supporting+%26+Related+Material&posted_year=2022", "selected": false}, {"value": 2023, "label": 2023, "count": 15, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=DEA&document_type=Supporting+%26+Related+Material&posted_year=2023", "selected": false}, {"value": 2018, "label": 2018, "count": 14, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=DEA&document_type=Supporting+%26+Related+Material&posted_year=2018", "selected": false}, {"value": 2012, "label": 2012, "count": 13, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=DEA&document_type=Supporting+%26+Related+Material&posted_year=2012", "selected": false}, {"value": 2024, "label": 2024, "count": 11, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=DEA&document_type=Supporting+%26+Related+Material&posted_year=2024", "selected": false}, {"value": 2010, "label": 2010, "count": 9, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=DEA&document_type=Supporting+%26+Related+Material&posted_year=2010", "selected": false}, {"value": 2011, "label": 2011, "count": 9, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=DEA&document_type=Supporting+%26+Related+Material&posted_year=2011", "selected": false}, {"value": 2026, "label": 2026, "count": 5, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=DEA&document_type=Supporting+%26+Related+Material&posted_year=2026", "selected": false}, {"value": 2008, "label": 2008, "count": 4, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=DEA&document_type=Supporting+%26+Related+Material&posted_year=2008", "selected": false}], "truncated": false}}, "suggested_facets": [{"name": "posted_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=DEA&document_type=Supporting+%26+Related+Material&_facet_date=posted_date"}, {"name": "last_modified", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=DEA&document_type=Supporting+%26+Related+Material&_facet_date=last_modified"}], "next": "2021-02-02T05~3A00~3A00Z,DEA-2020-0020-0004", "next_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=DEA&document_type=Supporting+%26+Related+Material&_next=2021-02-02T05~3A00~3A00Z%2CDEA-2020-0020-0004&_sort_desc=posted_date", "private": false, "allow_execute_sql": true, "query_ms": 2737.8667450975627, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}